Target intelligence / Profile preview

Transient receptor potential canonical 3 channel (TRPC3)

Target
TRPC3
Molecular classification
Ion channel, Nonselective cation channel, Transient receptor potential (TRP) channel family
01

Overview

Transient receptor potential canonical 3 channel (TRPC3) is a member of the transient receptor potential (TRP) channel family and functions as a nonselective, Ca^2+-permeable cation channel. It is broadly expressed in various tissues including brain, heart, endocrine glands, and smooth muscle, and is crucial for cellular calcium signaling. TRPC3 is directly activated by diacylglycerol downstream of G protein-coupled receptor activation and regulated by endogenous lipids, Ca^2+ ions, and protein interactions. Its physiological roles include mediation of store-operated and receptor-operated calcium entry, mitochondrial Ca^2+ uptake regulation, and protein scaffolding at the plasma membrane. TRPC3 is implicated in several pathologies, notably cardiovascular diseases (such as hypertension and cardiac fibrosis), neurodegenerative diseases, cancer, and inflammation, making it a significant therapeutic target[2][4][5][6][7][3][1].

Other names
TRPC3TRP-3Transient receptor potential cation channel subfamily C member 3
02

Mechanism of action

Channel blockers or modulators alter calcium influx by inhibiting or activating TRPC3-mediated cation flow; Antagonists prevent activation by endogenous lipids or diacylglycerol

03

Biological functions

Calcium signalingSignal transductionCellular homeostasisRegulation of mitochondrial membrane potentialProtein scaffold for downstream PKCbeta activation in B cells
04

Disease associations

Cardiovascular disease (including hypertension and cardiac fibrosis)Neurological diseasesCancerInflammation
05

Safety considerations

Potential off-target effects due to broad tissue expressiondisturbances in calcium homeostasisimpact on cardiac and neuronal function
06

Biomarkers

Increased TRPC3 expression may serve as a biomarker in vascular smooth muscle (e.g., hypertension)potential biomarker in cardiac or neurodegenerative diseases

Beyond the preview

Go deeper on Transient receptor potential canonical 3 channel (TRPC3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transient receptor potential canonical 3 channel (TRPC3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call